Santen Pharmaceutical Co., Ltd. is a prominent pharmaceutical company focusing on ophthalmology. Established in 1890 and headquartered in Osaka, Japan, Santen specializes in the research, development,... Santen Pharmaceutical Co., Ltd. is a prominent pharmaceutical company focusing on ophthalmology. Established in 1890 and headquartered in Osaka, Japan, Santen specializes in the research, development, and manufacturing of innovative eye care products. The company's portfolio includes a wide range of treatments for a variety of ophthalmic conditions such as glaucoma, dry eye, and retinal diseases. Santen has a strong emphasis on R&D to deliver advanced therapies and improve the quality of life for patients worldwide. Alongside traditional pharmaceutical products, the company also explores new areas such as digital ophthalmic solutions and regenerative medicine. Santen Pharmaceutical Co., Ltd. serves a global market, maintaining a significant presence in Europe and Asia, with a growing influence in North America. Its commitment to eye health, alongside strategic partnerships and a robust pipeline, position the company as a leader in the ophthalmology sector, contributing significantly to advancements in the treatment of eye diseases.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Santen Pharmaceutical

We have not yet reviewed Santen Pharmaceutical's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Santen Pharmaceutical's data?

Create a free Tracenable account to signal interest in having our team review data for Santen Pharmaceutical.

Legal Center Contact Us